Skip to main content
71°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Doug Drysdale
Recent news which mentions Doug Drysdale
Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming
June 03, 2025
Tickers
CYBN
Tags
CYBN
Benzinga
Doug Drysdale
From
Benzinga
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
November 13, 2024
Tickers
CYBN
Tags
Doug Drysdale
neuropsychiatric treatment
Benzinga
From
Benzinga
Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
November 15, 2023
Tickers
CYBN
Tags
CYBN
Cannabis
Psychedelics
From
Benzinga
Cybin Stock Down On Laying Off 15% Of Workforce As Part Of A Streamlining Clinical Alignment
February 23, 2023
Tickers
CYBN
Tags
Market News
premium
Benzinga
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
News
Markets
CYB004
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
James Lanthier
Market News
Cybin
From
Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
August 30, 2022
Tickers
CYBN
Tags
Success Stories
News
Psilocybin
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
Market News
Biotech
Benzinga
From
Benzinga
Cybin's Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder
June 28, 2022
Tickers
CYBN
Tags
General
Markets
FDA Approval
From
Benzinga
Cybin Closes Fiscal Year 2022, Reports Financial Results And Major Achievements
June 22, 2022
Tickers
CYBN
Tags
Management
CYBN
Cannabis
From
Benzinga
Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb Support
June 10, 2022
Tickers
CYBN
TWTR
Tags
TWTR
Doug Drysdale
Benzinga
From
Benzinga
Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
June 07, 2022
Tickers
CYBE
CYBN
ENTBF
Tags
Cannabis
CYBN
Small Cap
From
Benzinga
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog
May 31, 2022
Tickers
CYBN
Tags
Psychology
General
FDA Approval
From
Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Tickers
CYBN
Tags
Biotech
Benzinga
Doug Drysdale
From
Benzinga
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
April 19, 2022
Tickers
CYBN
DMT
PCC
Tags
Psilocybin
News
PCC
From
Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
Tickers
AGN
CYBN
PTX
Tags
Penny Stocks
Markets
Success Stories
From
Benzinga
Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event
February 14, 2022
Tickers
CYBN
FTRP
MMDCF
PSYC
Tags
PSYC
FTRP
Cannabis
From
Benzinga
Cybin Obtains U.S. Patent For Is Proprietary Compound Deuterated DMT Aimed At Treating Anxiety Disorders
February 09, 2022
Tickers
CYBN
Tags
Cannabis
Markets
CYBN
From
Benzinga
Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
January 11, 2022
Tickers
CYBN
FTRP
WSNAF
Tags
Market News
WSNAF
Doug Drysdale
From
Benzinga
Why Cybin Shares Are Rising
January 11, 2022
Tickers
CYBN
Tags
Trading Ideas
why it's moving
Market News
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Market News
Doug Drysdale
Benzinga
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
psychedelic thera
Psychedelics Therapy
News
From
Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Tickers
CMPS
CYBN
FLHLF
NMLSF
Tags
psychedelics
Penny Stocks
Ian McDonald
From
Benzinga
Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know
August 05, 2021
Tickers
CLXPF
CMPS
GBNH
Tags
Market News
CMPS
Doug Drysdale
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.